|
Originally published In Press as doi:10.1074/jbc.M106209200 on August 30, 2001
J. Biol. Chem., Vol. 276, Issue 44, 41112-41119, November 2, 2001
Formation of Crystalloid Endoplasmic Reticulum Induced by
Expression of Synaptotagmin Lacking the Conserved WHXL
Motif in the C Terminus
STRUCTURAL IMPORTANCE OF THE WHXL MOTIF IN THE C2B
DOMAIN*
Mitsunori
Fukuda §,
Akitsugu
Yamamoto¶, and
Katsuhiko
Mikoshiba
From the Laboratory for Developmental Neurobiology,
Brain Science Institute, RIKEN (The Institute of Physical and Chemical
Research), 2-1 Hirosawa, Wako, Saitama 351-0198, the ¶ Department
of Physiology, Kansai Medical University, Moriguchi, Osaka
570-8506, and the Department of Basic Medical Science,
Division of Molecular Neurobiology, The Institute of Medical
Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo
108-8639, Japan
Received for publication, July 3, 2001, and in revised form, August 23, 2001
 |
ABSTRACT |
Synaptotagmin (Syt) is a family of type I
membrane proteins that consists of a single transmembrane domain, a
spacer domain, two Ca2+-binding C2 domains, and a
short C terminus. We recently showed that deletion of the short C
terminus (17 amino acids) of Syt IV prevented the Golgi localization of
Syt IV proteins in PC12 cells and induced granular structures of
various sizes in the cell body by an unknown mechanism (Fukuda, M.,
Ibata, K., and Mikoshiba, K. (2001) J. Neurochem. 77, 730-740). In this study we showed by electron microscopy that these
structures are crystalloid endoplasmic reticulum (ER), analyzed the
mechanism of its induction, and demonstrated that: (a)
mutation or deletion of the evolutionarily conserved
WHXL motif in the C terminus of the synaptotagmin
family (Syt C) destabilizes the C2B domain structure
(i.e. causes misfolding of the protein), probably by
disrupting the formation of stable anti-parallel -sheets between the
-1 and -8 strands of the C2B domain; (b) the
resulting malfolded proteins accumulate in the ER rather than being
transported to other membrane structures (e.g. the Golgi
apparatus), with the malfolded proteins also inducing the expression of
BiP (immunoglobulin binding protein), one of the ER stress proteins;
and (c) the ERs in which the Syt C proteins have
accumulated associate with each other as a result of oligomerization capacity of the synaptotagmin family, because the Syt I C mutant, which lacks oligomerization activity, cannot induce crystalloid ER. Our
findings indicate that the conserved WHXL motif is
important not only for protein interaction site but for proper folding
of the C2B domain.
 |
INTRODUCTION |
Synaptotagmin I (Syt I)1
is an integral membrane protein of synaptic vesicles and a key molecule
that regulates various steps of the synaptic vesicle cycle. It consists
of a short intravesicular N terminus, a single transmembrane domain, a
spacer domain, a C2A domain, a C2B domain, and a short C terminus
(reviewed in Refs. 1-4). Each domain of Syt I has been shown to be
crucial to expression of its functions and to have a distinct role in the synaptic vesicle cycle. For instance, the short C terminus (WHXL motif) of Syt I is involved in synaptic vesicle
docking to the presynaptic plasma membrane, probably by binding to
certain plasma membrane receptors, such as neurexins (5). The
Ca2+ binding activity of the C2A domain is crucial
for synaptic vesicle fusion to the presynaptic plasma membrane, because
antibodies to the C2A domain that inhibits
Ca2+/phospholipid or Ca2+/syntaxin binding to
it interfere with the fusion step of secretory vesicles (6-11). The
Syt I C2A domain is also important for neurite outgrowth and the axonal
repair process (12-15). The C2B domain is involved in recycling of
synaptic vesicles, probably by binding to the clathrin assembly protein
AP-2 (16-18). The Ca2+-dependent
self-oligomerization activity of the C2B domain has also been suggested
to be involved in the fusion step of synaptic vesicles (19-22),
because a Tyr-312 to Asn substitution in the C2B domain of Syt II,
corresponding to the Drosophila AD3 mutation, impairs
Ca2+-dependent self-oligomerization activity
(20, 21), and inositol 1,3,4,5-tetrakisphosphate, a strong blocker of
neurotransmitter release, inhibits
Ca2+-dependent self-oligomerization activity of
the C2B domain in vitro (20, 23-25). In addition, the
phenotypes of Syt I mutants of Drosophila,
Caenorhabditis elegans, and mice strongly support the above
multiple functions of Syt I in the synaptic vesicle cycle (26-32).
Synaptotagmins are now known to form a large family of integral
membrane proteins in both vertebrates and invertebrates (1, 33, 34),
and it has been suggested that they regulate vesicular trafficking,
because Syts II-XIII basically share the same domain structure with
Syt I (i.e. a transmembrane domain, spacer domain, two C2
domains, and short C terminus). One of these domains, the N-terminal
region of the C terminus, is highly conserved across phyla as well as
different isoforms (Syts I-XIII), and it has been suggested to have
functions common to the synaptotagmin family (5, 35). In our previous
study, we showed that the WHXL motif in the C terminus of
Syts I-XI is essential for plasma membrane association in PC12 cells
and that the WHXL motif of Syt I regulates synaptic vesicle
docking to the presynaptic plasma membrane in the squid giant synapse
(5). In this study we report a novel role of the WHXL motif
of the synaptotagmin family in proper folding of the molecules. We have
shown by deletion and mutation analyses that the WHXL motif
is essential for correct folding of the C2B domain (i.e. the
WHXL motif is located in the -8 strand of the C2B domain
rather than being an independent domain; see Fig. 3A). Expression of synaptotagmin mutants lacking the WHXL motif
in cultured cells induced crystalloid endoplasmic reticulum (ER) structures (Refs. 36 and 37, and references therein) due to the
abnormal folding of the proteins. Based on these results, we discuss
the structural importance of the -8 strand of the C2 domains of synaptotagmins.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Recombinant Taq DNA polymerase and
restriction enzymes were obtained from Toyobo Biochemicals (Tokyo,
Japan). Mouse monoclonal antibody (M2) and rabbit polyclonal antibody
against FLAG peptide were obtained from Sigma Chemical Co. (St. Louis,
MO) and Zymed Laboratories Inc. (San Francisco, CA),
respectively. Horseradish peroxidase (HRP)-conjugated anti-T7 tag
antibody and anti-T7 tag antibody-conjugated agarose were from Novagen
(Madison, WI). HRP-conjugated anti-FLAG tag antibody was from Sigma.
Anti-TGN38 antibody was from Transduction Laboratories (Lexington, KY).
Anti-BiP (immunoglobulin binding protein, also called Grp78, a 78-kDa
glucose-regulated protein) antibody was from StressGen Biotechnologies
Corp. (Victoria, BC, Canada). All other chemicals were commercial
products of reagent grade. Solutions were made up in deionized water
prepared with an Elix10 water purification system and Milli-Q Biocel
A10 system (Millipore Corp., Bedford, MA).
Plasmid Construction--
pEF-FLAG(or T7)-Syts
I-XI, -Syts I-XI C, -T7-N-Gly-Syt VIII,
-T7-N-Gly-Syt IX, -T7-N-Gly-Syt VIII C,
-T7-N-Gly-Syt IX C, and -FLAG-Syt IV C2B were
essentially produced as described previously (5, 38-41). pEF-FLAG-Syt
IV 414-425, -Syt IV 419-425, -Syt IV 423-425, -Syt
IV 423-425(AAA), -Syt IV 329-425, -Syt IV 361-425, and -Syt IV(C2A) C were constructed by the polymerase chain reaction using the
following sets of primers with appropriate restriction enzyme sites
(underlined) and/ or termination codons (boldface letters): 5'-GCACTAGTTCACTTAGCAATTTGTC(AT)CC-3'
( 414/419 primer; antisense; amino acid residues 413-418),
5'-GCACTAGTTCAGAGCATGTGCCACT-3' ( 423 primer;
antisense; amino acid residues 418-422),
5'-GCACTAGTTCAGGCCATGGCCGCCTTAGCAATTTG-3' ( 423(AAA) primer; antisense; amino acid residues, 415-422),
5'-GCACTAGTCATTTGACGTAGGGATCTGAA-3' ( 329 primer, antisense; amino
acid residues 322-328), 5'-GCACTAGTCAAAAGACAAACAGTTCATTG-3' ( 361
primer, antisense; amino acid residues 354-360), and
5'-GCACTAGTCACATTAACATTTTTCCATC-3' (C2A C primer; antisense, amino acid residues 268-273).
pEF-FLAG-Syt IV C( 341-347) and -Syt IV C(K341A,
K342A,K346A) (KA) were essentially produced by means of
two-step polymerase chain reaction techniques as described previously
(25), using the following pairs of oligonucleotides: C2A primer,
5'-CGGATCCCAAGAGAAGCTGGGGACACT-3' and K/A primer,
5'-GCGTGCACTTCGCAACGTGAGTCGCCGCTTTAGAG-3' or K primer,
5'-GCGTGCACTTAGAGATTCTCTTCTT-3' (left half),
ApaLI primer, 5'-GCGTGCACTCCCAACGCAGTGTTC-3' and
C primer, 5'-GCACTAGTTCAGATCTCCTTCCAGTGCCC-3' (right half). pEF-FLAG-Syt IV(C2A- 1A3) and -Syt IV(C2A- 1) were similarly constructed using the following pairs of mutagenic
oligonucleotides: C2A- 1A3-5' primer,
5'-GACCAGAGCTGCAGCCCGGCCAGAAGACT-3' and C2A- 1A3-3' primer, 5'-TCTGGCCGGGCTGCAGCTCTGGTCTCTCT-3'; and
C2A- 1-5' primer, 5'-ACCGCGGCCAGAAGACTTCTT-3' and
C2A- 1-3' primer, 5'-
CCGCGGTACAAACACGCTCACTGTGGTG-3'. The resulting Syt IV
mutant fragments were subcloned into the NotI site of the
modified pEF-BOS mammalian expression vector (24, 42). All constructs
were verified by DNA sequencing using a Hitachi SQ-5500 DNA sequencer.
Plasmid DNA was prepared using Wizard-mini preps (Promega, Madison, WI)
or Qiagen (Chatsworth, CA) Maxi prep kits.
Immunocytochemistry--
Glass-bottom dishes (35 mm-dish, MatTek
Corp.) were coated with collagen type IV (Becton Dickinson, Bedford,
MA). PC12 cells (0.8-1 × 105 cells, the day before
transfection) were cultured on these dishes in Dulbecco's modified
Eagle's medium containing 10% horse serum and 10% fetal bovine serum
at 37 °C under 5% CO2. Transfection was achieved by
using the LipofectAMINE Plus reagent according to the manufacturer's
instructions (Life Technologies Inc., Gaithersburg, MD). Three days
after transfection, PC12 cells were fixed, permeabilized, and stained
with both rabbit anti-FLAG antibody (1/1000 dilution) and anti-TGN38
mouse monoclonal antibody (1/500 dilution) or anti-BiP mouse monoclonal
antibody (1/200 dilution), as described previously (43, 44).
Immunoreactivity was analyzed with a fluorescence microscope (TE300,
Nikon, Tokyo, Japan) attached to a laser confocal scanner unit CSU 10 (Yokogawa Electric Corp., Tokyo, Japan) and HiSCA charge-coupled
device camera (C6790, Hamamatsu Photonics, Hamamatsu, Japan).
Images were pseudo-colored and superimposed with Adobe Photoshop
software (Version 4.0).
Electron Microscopy--
PC12 cells cultured on collagen-coated
plastic coverslips (Sumitomo Bakelite, Tokyo, Japan) were fixed with
2.5% glutaraldehyde in 0.1 M sodium phosphate buffer (pH
7.4) for 2 h. After washing in the buffer, cells were post-fixed
in 1% OsO4 in 0.1 M sodium phosphate buffer
(pH 7.4) for 1 h. The cells were then washed in distilled water,
incubated with 50% ethanol for 10 min, and stained with 2% uranyl
acetate in 70% ethanol for 2 h. The cells were further dehydrated
with a graded series of ethanol and embedded in epoxy resin. Ultra-thin
sections were doubly stained with uranyl acetate and lead citrate and
then examined under a Hitachi H7000 electron microscope.
Synaptotagmin Oligomerization Assay--
pEF-T7-Syts and
pEF-FLAG-Syts were cotransfected into COS-7 cells (5 × 105 cells the day before transfection/10-cm dish) as
described previously (45). Three days after transfection, cells were
harvested and homogenized in 50 mM HEPES-KOH, pH 7.2, 250 mM NaCl, 0.1 mM phenylmethylsulfonyl fluoride,
10 µM leupeptin, and 10 µM pepstatin A. The
proteins expressed were solubilized with 1% Triton X-100,
immunoprecipitated with anti-T7 tag antibody-conjugated agarose, and
analyzed by 7.5% SDS-polyacrylamide gel electrophoresis (PAGE) as
previously described (38, 40, 45). Co-immunoprecipitated FLAG-Syts were
first detected with HRP-conjugated anti-FLAG antibody (1/10,000 dilution). The same blots were stripped and reprobed with
HRP-conjugated anti-T7 tag antibody to ensure loading of the same
amounts of T7-Syt proteins (1/10,000 dilution).
Endoglycosidase H Digestion of T7-N-Gly-synaptotagmins--
PC12
cells (4 × 106 cells, the day before transfection)
were cultured on 10-cm collagen type I-coated dishes (Becton Dickinson) in Dulbecco's modified Eagle's medium containing 10% horse serum and
10% fetal bovine serum at 37 °C under 5% CO2.
Transfection was achieved by using the LipofectAMINE Plus reagent as
described above. Immunoprecipitation of T7-Syts by anti-T7 tag
antibody-conjugated agarose was performed as described previously (38,
39, 45). The beads were resuspended in 30 µl of the buffer (50 mM sodium acetate, pH 5.3, 0.1% SDS, 0.5% IGEPAL
CA-630 (Sigma Chemical Co.), 0.1 mM phenylmethylsulfonyl
fluoride, 10 µM leupeptin, and 10 µM
pepstatin A) and then divided into two microtubes. After denaturation
by boiling for 3 min and cooling to 37 °C, 5 milliunits of
endoglycosidase H (Roche Diagnostics, Mannheim, Germany) was added to
one tube, and the mixtures were incubated for 1 h at 37 °C
(41). Reactions were stopped by adding SDS sample buffer and boiling
for 3 min. Proteins were subjected to 10% SDS-PAGE and immunoblotting
with HRP-conjugated anti-T7 tag antibody as described previously
(38-40).
Trypsin Digestion of Recombinant C2B Domain of Synaptotagmin
IV--
Syt IV-C2B 423-425 and mutant Syt IV-C2B 423-425(AAA)
fused to glutathione S-transferase (GST) were prepared by a
standard method (24, 46), and after incubating 4 µg of GST fusion
proteins in 10 mM Tris-HCl, pH 7.5, and 100 mM
NaCl with 1 ng/µl trypsin (Sigma Chemical Co.) for 0-30 min at
25 °C, the reactions were stopped by addition of SDS sample buffer
and boiling for 3 min. Samples were then analyzed by 12.5% SDS-PAGE
and staining with Coomassie Brilliant Blue R-250.
 |
RESULTS |
Induction of Crystalloid ER by Expression of Synaptotagmin IV
Lacking the WHXL Motif--
In the course of determining the Golgi
localization signal of Syt IV in PC12 cells, we found that the deletion
of the short C terminus (amino acid residues 409-425) prevented the
Golgi localization of Syt IV and induced large granular structures of
various sizes (Ref. 41 and Fig. 1,
A and C). Interestingly, these granular structures in which Syt IV C proteins had accumulated were easily identified on light-field micrographs (arrowheads in Fig.
1D). Because they were also positive with anti-BiP antibody,
a marker for the ER, we suspected that they represented crystalloid ER (36, 37; see also Fig. 1, E-G, arrows). Electron
microscopic observation of the cells expressing Syt IV C revealed a
unique membranous structure characteristic to "crystalloid ER" (36,
37), which is composed of tightly packed smooth ER cisternae (Fig.
3H, arrowheads) or tubules (Fig. 3H,
arrows). The crystalloid ER was occasionally continuous to
rough ER cisternae (Fig. 3H, small
arrows).

View larger version (62K):
[in this window]
[in a new window]
|
Fig. 1.
Deletion of the short C terminus prevents
Golgi localization of synaptotagmin IV and induces crystalloid ER.
FLAG-Syt IV (A, B) and -Syt IV C
(C-H) proteins were expressed in PC12 cells as
described under "Experimental Procedures." PC12 cells were fixed,
permeabilized, and stained with anti-FLAG rabbit antibody
(green in A, C, E, and
G) and anti-BiP antibody (red in F and
G). B and D are light-field
micrographs of A and C, respectively. The
inset in D is a superposition of C and
D. Note that the granules could be detected by light-field
microscopy (arrowheads in D) and that they
colocalized with BiP (arrows in E-G).
H, electron micrograph of PC12 cells expressing FLAG-Syt
IV C proteins. The crystalloid ER is composed of tightly packed
smooth ER cisternae (arrowheads in H) or tubule
(arrows in H). The crystalloid ER was
occasionally continuous to rough ER cisternae (small arrows
in H). DCV, dense-core vesicle; RER,
rough ER; M, mitochondria. Scale bars in
G and H indicate 20 µm and 500 nm,
respectively.
|
|
To identify the amino acid residues responsible for the induction of
crystalloid ER by expression of Syt IV C, we constructed various
additional C-terminal deletion mutants (Fig.
2A). After deletion of more
than seven amino acids from the C terminus (FLAG-Syt IV 419-425), we
observed mis-sorting of Syt IV mutant proteins and formation of
crystalloid ER of various sizes within the cell body (Fig.
2C, 414-425, 419-425 in green and TGN38
in red), but deletion of three amino acids did not affect
the Golgi localization of Syt IV (Fig. 2C, 423-425,
arrowheads). When the conserved WHML (amino acids 419-422)
sequences were mutated to AAMA, expression of FLAG-Syt
IV 423-425(AAA) induced granule formation similar to that of Syt
IV C (Fig. 2C). Thus, the WHXL sequences are in some way related to the formation of crystalloid ER and the Golgi localization of Syt IV. Because deletion of the whole C2B domain (FLAG-Syt IV C2B) attenuated the crystalloid ER formation induced by
deletion of the C terminus ( C) and Syt IV C2B proteins were localized in the Golgi (Fig. 2C, arrowhead in
center panel), the C2B domain was further systematically
deleted from the C terminus, and the putative effector domain of the
C2B domain was deleted or mutated to clarify the relationship between
the C2B domain and the WHXL sequences (Fig. 2C)
(25, 47, 48). These mutations and deletions, however, failed to restore
the Golgi localization of Syt IV C proteins (Fig. 2C,
329-425, 361-425, C(341-347), and C(KA) in
green and TGN38 in red).

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Expression of synaptotagmin IV lacking the
WHXL motif induces crystalloid ER in PC12 cells.
A, schematic representation of the C-terminal mutants of Syt
IV. B, schematic representation of the C2B deletion mutants
of Syt IV. FLAG tags, the transmembrane domain (TM), and two
C2 domains are represented by black boxes, open
boxes, and hatched boxes, respectively. The
double dots and dashes indicate amino acids
identical to the top sequence and deletions, respectively. Amino acid
substitutions are indicated by the single-letter amino acid code
below the wild-type sequences (bottom lines in
A and B). Amino acid numbers, except for the FLAG
tag sequence, are given on the right. C,
subcellular localization of the C-terminal and C2B deletion mutants of
FLAG-Syt IV 414-425, -Syt IV 419-425, -Syt IV 423-425, -Syt
IV 423-425(AAA), -Syt IV C2B, -Syt IV 329-425, -Syt
IV 361-425, -Syt IV C( 341-347), and -Syt IV C(KA) were
expressed in PC12 cells as described under "Experimental
Procedures." PC12 cells were fixed, permeabilized, and stained with
both anti-FLAG rabbit (green) and anti-TGN38 antibodies, a
marker for the TGN (red). Note that only FLAG-Syt
IV 423-425 and -Syt IV C2B overlapped well with TGN38
(arrowheads). Scale bar indicates 20 µm.
|
|
The Formation of Crystalloid ER Structures by Expression of Other
Synaptotagmins Lacking the WHXL Motif--
The WHXL motif
is highly conserved among the C-terminal type tandem C2 proteins,
including the synaptotagmin family, rabphilin-3A, the Doc2 family, and
the Slp family (synaptotagmin-like
protein) (35, 49, 50) and was proposed to be an independent
domain (4), because the short C terminus of these proteins interacts with polymorphic plasma membrane receptors, neurexins, in
vitro (33, 49, 51-54). However, recent demonstration of the
three-dimensional structure of the C2B domain of Syt III (55) and
rabphilin-3A (56) has provided strong evidence against this notion, and
the WHXL motif must be a part of the C2B domain rather than
an independent domain. The C2B domain of Syt III is composed of an
eight-stranded anti-parallel -sandwich structure consisting of
four-stranded -sheets (anti-parallel pairing of -1 and -8,
-2 and -5, -3 and -4, and -6 and -7 strands), the
same as the Syt I C2A domain (reviewed in Ref. 57; see also Fig.
3A). The major difference between the C2A and C2B domains is that the C2B domain contains an
additional -helix region between the -7 and -8 strands (Fig. 3A). It should be noted that this -helix region was
previously thought to be a -8 strand of the C2B domain (Fig.
3B, broken arrow) (55, 56). Based on these
findings, together with the fact that crystalloid ER is induced by
expression of malfolded proteins (58), we hypothesized that deletion of
a portion of the -8 strand (the WHXL motif) of the C2B
domain destabilizes the C2B domain structure (i.e. the C2B
domain lacking the WHXL motif cannot fold correctly) and
induces the crystalloid ER structures.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
Proposed structure of the C2B domain of
synaptotagmins. A, schematic representation of the C2B
domain of synaptotagmin IV (modified from Ref. 57). The
arrows represent eight strands of the C2B domain
( 1- 8). Three loops are formed at the tip of the -sandwich
structure, and two of them are involved in Ca2+-binding in
the C2A domain of Syt I (57). The overall structure of the C2B domain
is quite similar to the C2A domain, but an additional -helix is
present between the -7 and -8 strands in the C2B domain (55, 56).
Note that the N-terminal -1 strand and C-terminal -8 strand form
a pair to create an anti-parallel -sheet. B, sequence
alignment of the -1 and -8 strands (solid arrows) and
the -helix (broken line) of the Syts I-XIII C2B domains
(33, 38, 55). Asterisks indicate the conserved
WHXL motif (5). The number signs indicate the
positions of amino acid substitutions (GEL-to-AAA) in the Syt
IV(C2B- 1A3) mutant (see also Fig. 5A). Note that the
-helix region was previously thought to be a -8 strand of the C2B
domain by analogy with the C2A domain ( 8', broken arrow
at the bottom) (57).
|
|
If this hypothesis were true, deletion of the -8 strand of the C2B
domain of other synaptotagmin isoforms should induce the same
crystalloid ER structures, because the WHXL motif is highly conserved in the synaptotagmin family (Fig. 3B). As
expected, expression of Syts I-XI C proteins also induced
crystalloid ER-like structures in PC12 cells (Fig.
4A, arrowheads and
data not shown), although the appearance of the crystalloid ER-like
structures differs according to the Syt isoform (5-50% of total
cells). Interestingly, expression of an Syt I C mutant that lacks
oligomerization activity (Fig. 4B; Syt I spacer/ C) (59)
failed to induce crystalloid ER-like structures, despite the absence of
the WHXL motif (Fig. 4A, right upper
panel).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Induction of crystalloid ER-like structures
by C-terminal truncation of the synaptotagmin family.
A, FLAG-Syt I C, -Syt I spacer/ C, -Syt VI C, and
-Syt XI C were expressed in PC12 cells as described under
"Experimental Procedures." PC12 cells were fixed, permeabilized,
and stained with anti-FLAG antibody. Note that the crystalloid ER-like
structures were induced by expression of Syt I C, Syt VI C, and Syt
XI C (arrowheads), but not Syt I spacer/ C, which did
not exhibit Ca2+-independent oligomerization activity (59)
(see also B). Scale bar indicates 20 µm.
B, oligomerization activity of Syt I C (or Syt
I spacer/ C). pEF-T7-Syt I and FLAG-Syt I C (or -Syt
I spacer/ C) were co-transfected into COS-7 cells. Association
between T7-Syt I and FLAG-Syt I C (or -Syt I spacer/ C) was
evaluated by immunoprecipitation with anti-T7 tag antibody-conjugated
agarose (IP) as described previously (38, 45). Top
panel, total expressed FLAG-Syt I C and -Syt I spacer/ C
(1/40 volumes of reaction mixtures; input) used for
immunoprecipitation. Middle panel, co-immunoprecipitated
FLAG-tagged proteins (blot: anti-FLAG).
Lower panel, immunoprecipitated T7-Syt I (blot:
anti-T7). The arrow indicates the SDS-resistant
dimer of Syt I C. The positions of the molecular weight
(Mr) markers (×10 3) are shown on
the left.
|
|
Next, we focused on the -1 strand of the C2B domain of Syt IV,
because the N-terminal -1 strand and C-terminal -8 strand pair to
form anti-parallel -sheets (Fig. 3A). Deletion of the -1 strand of the C2B domain of Syt IV (C2B- 1, Fig.
5) or substitution of AAA for the
conserved G(E/D)(L/I) sequence of the -1 strand of Syt IV
(C2B- 1A3) induced crystalloid ER-like structures, the same as Syt
IV C, suggesting that pairing of the -1 and -8 strands is
important for proper folding of the C2B domain. These results, together
with the fact that the basic structure of both the C2A and C2B domains
is the same (55-57), prompted to us to examine whether deletion of the
-8 strand of the C2A domain would also induce crystalloid ER. As
expected, expression of Syt IV(C2A) C proteins induced the same
crystalloid ER-like structures (Fig. 5B, top
panel).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 5.
Expression of synaptotagmin IV lacking
the -1 strand of the C2B domain or
-8 strand of the C2A domain induces crystalloid
ER-like structures in PC12 cells. A, schematic
representation of the -1 (or -8) strand-mutants of Syt IV.
B, subcellular localization of the -1 and -8
strand-mutants of Syt IV. FLAG-Syt IV(C2A) C, -Syt IV(C2B- 1),
and -Syt IV(C2B- 1A3) were expressed in PC12 cells as described under
"Experimental Procedures." PC12 cells were fixed, permeabilized,
and stained with anti-FLAG antibody. In all cases, crystalloid ER-like
structures were induced. Scale bar indicates 20 µm.
|
|
Incomplete Post-translational Modifications of Syt C Proteins in
PC12 Cells--
Vertebrate Syts I and II contain a single
N-glycosylation site in the N-terminal intravesicular domain
(24, 39, 41, 51, 60), and the N-liked sugars are further
converted to complex oligosaccharides in the Golgi of PC12 cells (41).
Because the dense-core vesicles where Syt I is abundant are thought to
be derived from the TGN (trans-Golgi network) in PC12 cells,
we decided to investigate whether Syt I C proteins pass through the
Golgi and TGN or are only retained in the ER. To do so, we used
endoglycosidase H, which cleaves unmodified N-linked sugars
but not complex oligosaccharides (41). The N-linked sugars
of the wild-type T7-Syt I, -Syt II, -N-Gly-Syt VIII, and
-N-Gly-Syt IX in PC12 cells were further modified and were
resistant to endoglycosidase H treatment, whereas the mutant proteins
(Syt C) were mostly sensitive to endoglycosidase H (Fig.
6, A and B). By
contrast, the N-linked sugars of both the wild-type and
mutant proteins were cleaved by N-glycosidase F, which
cleaves all N-linked sugars, regardless of modifications (data not shown). These results indicate that the newly synthesized Syt
C proteins had been correctly inserted into the ER membrane and had
been retained in the ER without being transported to the Golgi, where
complex modification occurs.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
Analysis of T7-Syts
I C, II C,
T7-N-Gly-Syts VIII C, and
IX C by endoglycosidase H treatment.
A, treatment of T7-Syt I, -Syt I C, -Syt II, and -Syt
II C with endoglycosidase H (endo H). T7-Syts were
expressed in PC12 cells and immunoprecipitated by anti-T7 tag
antibody-conjugated agarose as described previously (38, 45).
Immunoprecipitants were exposed to or not exposed to glycosidase,
subjected to 10% SDS-PAGE, and then analyzed by immunoblotting with
HRP-conjugated anti-T7 tag antibody. Note that Syts I and II were
resistant to endoglycosidase H (broken boxed), but Syts
I C and II C were highly sensitive to endoglycosidase H. The
results shown are representative of three independent experiments. The
positions of the Mr markers
(×10 3) are shown on the left. B,
proportion of the endoglycosidase H-resistant band of T7-Syts I, II,
T7-N-Gly-Syts VIII, IX (black columns), I C,
II C, T7-N-Gly-Syts VIII C, and IX C (white
columns). Immunoreactive bands in A were captured by
Gel Print 2000i/VGA (Bio Image) and quantified by Basic Quantifier
Software (version 1.0) (Bio Image). Columns indicate the
proportion of endoglycosidase H-resistant bands (i.e. the
proportion of proteins that were modified in the Golgi).
Bars indicate the S.D. of three independent
experiments.
|
|
Essential Role of the WHXL Motif in the C2B Domain
Structure--
Finally, we investigated whether the WHXL
motif is essential for the proper folding of the C2B domain
biochemically by monitoring its sensitivity to proteolysis. If the
above hypothesis were correct, mutation of the WHXL motif to
AAXA would cause it to fail to form a stable C2 domain
structure by disrupting the pairing of the -1 and -8 strands, and
the mutant proteins should be more sensitive to proteinase than the
wild-type proteins. When the GST-Syt IV-C2B 423-425 proteins
(including the WHXL motif) were treated with low
concentrations of trypsin, they were rapidly cut into two pieces at the
fusion site between GST (open arrowheads) and Syt IV-C2B
(asterisk in Fig. 7,
upper panel). The C2B 423-425 proteins (including the WHXL motif) were highly resistant during 30 min of
incubation at this concentration of trypsin, whereas the mutant C2B
domains were degraded within 10 min. Thus, the WHXL motif
was indeed found to be essential for the packed C2B domain
structure.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 7.
Limited proteolysis of the C2B domain of
synaptotagmin IV. After incubating 4 µg of GST-Syt
IV-C2B 423-425 (upper panel) and -C2B 423-425(AAA)
(lower panel) in 10 mM Tris-HCl, pH 7.5, and 100 mM NaCl with 1 ng/µl trypsin for 0-30 min at 25 °C,
the reactions were stopped by addition of SDS sample buffer and boiling
for 3 min. Samples were then analyzed by 12.5% SDS-PAGE and staining
with Coomassie Brilliant Blue R-250. GST-Syt IV-C2B (closed
arrowheads) was rapidly cut into two pieces at the fusion site
between GST (open arrowheads) and Syt IV-C2B
(asterisk). Note that the Syt IV-C2B 423-425 proteins
were highly resistant to 1 ng/µl trypsin, whereas the mutant Syt
IV-C2B 423-425(AAA) proteins were degraded within 10 min. The
results shown are representative of two independent experiments.
|
|
 |
DISCUSSION |
We previously found that deletion of 17 amino acids C-terminal of
Syt IV induced granular structures and prevented the Golgi localization
of Syt IV (41). In this study we showed by electron microscopy that
this granular structure is crystalloid ER (36, 37) and analyzed the
mechanism of its induction by expression of Syts I-XI lacking the
conserved WHXL motif in the C terminus. Crystalloid ER was
found to be induced by following processes: (a) Mutation or
deletion of the conserved amino acids in the -1 or -8 strand
(e.g. GE/DL/I in the -1 strand or WHXL in the
-8 strand; see Fig. 3B) in the C2 domain destabilizes one
of the four-stranded -sheets (i.e. anti-parallel pairing
of the N-terminal -1 strand and the C-terminal -8 strand),
preventing the mutant proteins from folding correctly. Misfolding of
the C2B domain lacking the WHXL motif was confirmed by
limited proteolysis (Fig. 7). Because anti-parallel pairing of other
-sheets occurred between adjacent -3 and -4 or -6 and -7
strands (57), we speculate that mutations or deletions in the
-sheets formed by the N-terminal -1 strand and the C-terminal
-8 strand add a most striking effect to C2 domain structure.
(b) The resulting malfolded proteins are correctly inserted
into the ER (showing type I membrane topology) but then are not
transported to the Golgi (Fig. 6) and accumulate in the ER.
Accumulation of the malfolded proteins in the ER induces the expression
of BiP, one of the ER stress proteins, which are known to be induced by
accumulation of malfolded proteins and to be present in stable
complexes in the malfolded proteins (61, 62). Consistent with this, Syt
IV C proteins colocalized with BiP in the crystalloid ER (Fig. 1,
E-G, arrows). Because the cytoplasmic domain of
Syts I-XI lacking the WHXL motif (Syt-cyto C) was
expressed in the cytosol, and its expression could not induce
crystalloid ER (5, 43), malfolded proteins seem to be recognized only in the ER. (c) We previously proposed that crystalloid ER is
formed by head-to-head association of malfolded molecules on apposed smooth ER membranes based on the results of an experiment using rat
liver microsomal aldehyde dehydrogenase (37). It should be noted that
the synaptotagmin family also shows Ca2+-independent
oligomerization activity via around the spacer domain and/or
fatty-acylated Cys cluster at the interface between the transmembrane
and spacer domains, and disulfide bonding at the extracellular domain
(17, 38-40, 59). Indeed, the expression of Syt I spacer/ C
proteins, which lack oligomerization activity, could not induce
crystalloid ER (Fig. 4). Therefore, it is most likely that the ERs in
which Syt C proteins have accumulated associate with each other to
form crystalloid ER as a result of the oligomerizing capacity of the
Syt family.
Because the WHXL motif was first proposed to be an
independent domain based on sequence comparisons with the C2A domain
structure (4), many in vitro binding experiments
investigating the C2B domain, including our own, have involved the use
of recombinant C2B domains lacking the WHXL motif
(i.e. -8 strand), as minimum C2B domains (25, 48, 63, 64,
66). Accordingly, some in vitro binding experiments
on the C2B domain should be re-evaluated in terms of ligand binding
specificity or ligand affinity. Indeed, we found that the C2B domain
lacking the WHXL motif showed weaker Ca2+-dependent oligomerization activity in Syt
VII than the wild-type protein (45) and found distinct inositol
polyphosphate binding specificity in Syt II (24). Based on these
findings, we suggest that differences in the length of the C terminus
of the recombinant C2B domain, in addition to the impurity of
recombinant proteins (67), are another important factor responsible for
the contradictory results obtained in regard to the in vitro
binding properties of the C2B domain (48, 65, 68-70).
Krasnov and Enikolopov (35) recently reported that mutation or deletion
of the C terminus of Syt II prevented it from being transported to the
tips of neurites where dense-core vesicles are abundant in nerve growth
factor-differentiated PC12 cells, and they proposed that the
WHXL motif is an active signal for targeting to the tips of
neurites. However, our finding that the malfolded Syt C proteins
lacking the WHXL motif are retained in the ER provides
strong evidence against this idea. We suggest that Syt II C proteins
accumulate in the ER, are not transported to the Golgi, and,
consequently, are not present in the dense-core vesicles derived from
the TGN.
In conclusion, we have demonstrated that the WHXL motif
functions as a protein interaction site (e.g. neurexins) as
well as being important for proper folding of the C2B domain to
stabilize anti-parallel -sheet formation between -1 and -8
strands. We propose that recombinant C2B domains that contain the
entire C terminus should be used for in vitro binding
experiments to avoid abnormal folding of the C2B domain, which is only
evident in the ER of living cells.
 |
ACKNOWLEDGEMENTS |
We thank Eiko Kanno, Chika Saegusa, and Yukie
Ogata for technical assistance.
 |
FOOTNOTES |
*
This work was supported by grants from the Science and
Technology Agency to Japan (to K. M.) and Grants 13780624 from the Ministry of Education, Science, and Culture of Japan (to M. F.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Laboratory for
Developmental Neurobiology, Brain Science Institute, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan. Tel.: 81-48-467-9745; Fax:
81-48-467-9744; E-mail: mnfukuda@brain.riken.go.jp.
Published, JBC Papers in Press, August 30, 2001, DOI 10.1074/jbc.M106209200
 |
ABBREVIATIONS |
The abbreviations used are:
Syt(s), synaptotagmin(s);
ER, endoplasmic reticulum;
GST, glutathione
S-transferase;
HRP, horseradish peroxidase;
PAGE, polyacrylamide gel electrophoresis;
TGN, trans-Golgi
network;
BiP, immunoglobulin heavy chain binding
protein.
 |
REFERENCES |
| 1.
|
Marquèze, B.,
Berton, F.,
and Seagar, M.
(2000)
Biochimie (Paris)
82,
409-420
|
| 2.
|
Fukuda, M.,
and Mikoshiba, K.
(1997)
Bioessays
19,
593-603
|
| 3.
|
Schiavo, G.,
Osborne, S. L.,
and Sgouros, J. G.
(1998)
Biochem. Biophys. Res. Commun.
248,
1-8
|
| 4.
|
Südhof, T. C.,
and Rizo, J.
(1996)
Neuron
17,
379-388
|
| 5.
|
Fukuda, M.,
Moreira, J. E.,
Liu, V.,
Sugimori, M.,
Mikoshiba, K.,
and Llinás, R. R.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14715-14719
|
| 6.
|
Mikoshiba, K.,
Fukuda, M.,
Moreira, J. E.,
Lewis, F. M. T.,
Sugimori, M.,
Niinobe, M.,
and Llinás, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10703-10707
|
| 7.
|
Mochida, S.,
Fukuda, M.,
Niinobe, M.,
Kobayashi, H.,
and Mikoshiba, K.
(1997)
Neuroscience
77,
937-943
|
| 8.
|
Ohara-Imaizumi, M.,
Fukuda, M.,
Niinobe, M.,
Misonou, H.,
Ikeda, K.,
Murakami, T.,
Kawasaki, M.,
Mikoshiba, K.,
and Kumakura, K.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
287-291
|
| 9.
|
Lang, J.,
Fukuda, M.,
Zhang, H.,
Mikoshiba, K.,
and Wollheim, C. B.
(1997)
EMBO J.
16,
5837-5846
|
| 10.
|
Sugimori, M.,
Tong, C.-K.,
Fukuda, M.,
Moreira, J. E.,
Kojima, T.,
Mikoshiba, K.,
and Llinás, R.
(1998)
Neuroscience
86,
39-51
|
| 11.
|
Thomas, D. M.,
and Elferink, L. A.
(1998)
J. Neurosci.
18,
3511-3520
|
| 12.
|
Kabayama, H.,
Takei, K.,
Fukuda, M.,
Ibata, K.,
and Mikoshiba, K.
(1999)
Neuroscience
88,
999-1003
|
| 13.
|
Detrait, E.,
Eddleman, C. S.,
Yoo, S.,
Fukuda, M.,
Nguyen, M. P.,
Bittner, G. D.,
and Fishman, H. M.
(2000)
J. Neurobiol.
44,
382-391
|
| 14.
|
Detrait, E. R.,
Yoo, S.,
Eddleman, C. S.,
Fukuda, M.,
Bittner, G. D.,
and Fishman, H. M.
(2000)
J. Neurosci. Res.
62,
566-573
|
| 15.
|
Fukuda, M.,
and Mikoshiba, K.
(2000)
Neurosci. Lett.
295,
33-36
|
| 16.
|
Fukuda, M.,
Moreira, J. E.,
Lewis, F. M. T.,
Sugimori, M.,
Niinobe, M.,
Mikoshiba, K.,
and Llinás, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10708-10712
|
| 17.
|
von Poser, C.,
Zhang, J. Z.,
Mineo, C.,
Ding, W.,
Ying, Y.,
Südhof, T. C.,
and Anderson, R. G. W.
(2000)
J. Biol. Chem.
275,
30916-30924
|
| 18.
|
Haucke, V.,
Wenk, M. R.,
Chapman, E. R.,
Farsad, K.,
and De Camilli, P.
(2000)
EMBO J.
19,
6011-6019
|
| 19.
|
Bommert, K.,
Charlton, M. P.,
DeBello, W. M.,
Chin, G. J.,
Betz, H.,
and Augustine, G. J.
(1993)
Nature
363,
163-165
|
| 20.
|
Fukuda, M.,
Kabayama, H.,
and Mikoshiba, K.
(2000)
FEBS Lett.
482,
269-272
|
| 21.
|
Littleton, J. T.,
Bai, J.,
Vyas, B.,
Desai, R.,
Baltus, A. E.,
Garment, M. B.,
Carlson, S. D.,
Ganetzky, B.,
and Chapman, E. R.
(2001)
J. Neurosci.
21,
1421-1433
|
| 22.
|
Desai, R. C.,
Vyas, B.,
Earles, C. A.,
Littleton, J. T.,
Kowalchyck, J. A.,
Martin, T. F. J.,
and Chapman, E. R.
(2000)
J. Cell Biol.
150,
1125-1136
|
| 23.
|
Llinás, R.,
Sugimori, M.,
Lang, E. J.,
Morita, M.,
Fukuda, M.,
Niinobe, M.,
and Mikoshiba, K.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12990-12993
|
| 24.
|
Fukuda, M.,
Aruga, J.,
Niinobe, M.,
Aimoto, S.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
29206-29211
|
| 25.
|
Fukuda, M.,
Kojima, T.,
Aruga, J.,
Niinobe, M.,
and Mikoshiba, K.
(1995)
J. Biol. Chem.
270,
26523-26527
|
| 26.
|
Geppert, M.,
Goda, Y.,
Hammer, R. E.,
Li, C.,
Rosahl, T. W.,
Stevens, C. F.,
and Südhof, T. C.
(1994)
Cell
79,
717-727
|
| 27.
|
DiAntonio, A.,
Parfitt, K. D.,
and Schwarz, T. L.
(1993)
Cell
73,
1281-1290
|
| 28.
|
Littleton, J. T.,
Stern, M.,
Schulze, K.,
Perin, M.,
and Bellen, H. J.
(1993)
Cell
74,
1125-1134
|
| 29.
|
Nonet, M. L.,
Grundahl, K.,
Meyer, B. J.,
and Rand, J. B.
(1993)
Cell
73,
1291-1305
|
| 30.
|
Jorgensen, E. M.,
Hartwieg, E.,
Schuske, K.,
Nonet, M. L.,
Jin, Y.,
and Horvitz, H. R.
(1995)
Nature
378,
196-199
|
| 31.
|
Reist, N. E.,
Buchanan, J.,
Li, J.,
DiAntonio, A.,
Buxton, E. M.,
and Schwarz, T. L.
(1998)
J. Neurosci.
18,
7662-7673
|
| 32.
|
Fernandez-Chacon, R.,
Konigstorfer, A.,
Gerber, S. H.,
Garcia, J.,
Matos, M. F.,
Stevens, C. F.,
Brose, N.,
Rizo, J.,
Rosenmund, C.,
and Südhof, T. C.
(2001)
Nature
410,
41-49
|
| 33.
|
Fukuda, M.,
and Mikoshiba, K.
(2001)
Biochem. J.
354,
249-257
|
| 34.
|
Lloyd, T. E.,
Verstreken, P.,
Ostrin, E. J.,
Phillippi, A.,
Lichtarge, O.,
and Bellen, H. J.
(2000)
Neuron
26,
45-50
|
| 35.
|
Krasnov, P. A.,
and Enikolopov, G.
(2000)
J. Cell Sci.
113,
1389-1404
|
| 36.
|
Pathak, R. K.,
Luskey, K. L.,
and Anderson, R. G. W
(1986)
J. Cell Biol.
102,
2158-2168
|
| 37.
|
Yamamoto, A.,
Masaki, R.,
and Tashiro, Y.
(1996)
J. Cell Sci.
109,
1727-1738
|
| 38.
|
Fukuda, M.,
Kanno, E.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31421-31427
|
| 39.
|
Fukuda, M.,
and Mikoshiba, K.
(2000)
J. Biochem. (Tokyo)
128,
637-645
|
| 40.
|
Fukuda, M.,
and Mikoshiba, K.
(2000)
J. Biol. Chem.
275,
28180-28185
|
| 41.
|
Fukuda, M.,
Ibata, K.,
and Mikoshiba, K.
(2001)
J. Neurochem.
77,
730-740
|
| 42.
|
Mizushima, S.,
and Nagata, S.
(1990)
Nucleic Acids Res.
18,
5332
|
| 43.
|
Fukuda, M.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
31428-31434
|
| 44.
|
Ibata, K.,
Fukuda, M.,
Hamada, T.,
Kabayama, H.,
and Mikoshiba, K.
(2000)
J. Neurochem.
74,
518-526
|
| 45.
|
Fukuda, M.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
27670-27676
|
| 46.
|
Smith, D. B.,
and Johnson, K. S.
(1988)
Gene
67,
31-40
|
| 47.
|
Mizutani, A.,
Fukuda, M.,
Niinobe, M.,
and Mikoshiba, K.
(1997)
Biochem. Biophys. Res. Commun.
240,
128-131
|
| 48.
|
Chapman, E. R.,
Desai, R. C.,
Davis, A. F.,
and Tornehl, C. K.
(1998)
J. Biol. Chem.
273,
32966-32972
|
| 49.
|
Fukuda, M.,
and Mikoshiba, K.
(2001)
Biochem. Biophys. Res. Commun.
281,
1226-1233
|
| 50.
|
Fukuda, M.,
Saegusa, C.,
and Mikoshiba, K.
(2001)
Biochem. Biophys. Res. Commun.
283,
513-519
|
| 51.
|
Perin, M. S.,
Brose, N.,
Jahn, R.,
and Südhof, T. C.
(1991)
J. Biol. Chem.
266,
623-629
|
| 52.
|
Petrenko, A. G.,
Perin, M. S.,
Davletov, B. A.,
Ushkaryov, Y. A.,
Geppert, M.,
and Südhof, T. C.
(1991)
Nature
353,
65-68
|
| 53.
|
Hata, Y.,
Davletov, B.,
Petrenko, A. G.,
Jahn, R.,
and Südhof, T. C.
(1993)
Neuron
10,
307-315
|
| 54.
|
Perin, M. S.
(1996)
Biochemistry
35,
13808-13816
|
| 55.
|
Sutton, R. B.,
Ernst, J. A.,
and Brunger, A. T.
(1999)
J. Cell Biol.
147,
589-598
|
| 56.
|
Ubach, J.,
Garcia, J.,
Nittler, M. P.,
Südhof, T. C.,
and Rizo, J.
(1999)
Nat. Cell Biol.
1,
106-111
|
| 57.
|
Nalefski, E. A.,
and Falke, J. J.
(1996)
Protein Sci.
5,
2375-2390
|
| 58.
|
Ishihara, N.,
Yamashina, S.,
Sakaguchi, M.,
Mihara, K.,
and Omura, T.
(1995)
J. Biochem. (Tokyo)
118,
397-404
|
| 59.
|
Fukuda, M.,
Kanno, E.,
Ogata, Y.,
and Mikoshiba, K.
(2001)
J. Biol. Chem.
276,
40319-40325
|
| 60.
|
Kida, Y.,
Sakaguchi, M.,
Fukuda, M.,
Mikoshiba, K.,
and Mihara, K.
(2000)
J. Cell Biol.
150,
719-730
|
| 61.
|
Kozutsumi, Y.,
Segal, M.,
Normington, K.,
Gething, M. J.,
and Sambrook, J.
(1988)
Nature
332,
462-464
|
| 62.
|
Lenny, N.,
and Green, M.
(1991)
J. Biol. Chem.
266,
20532-20537
|
| 63.
|
Ibata, K.,
Fukuda, M.,
and Mikoshiba, K.
(1998)
J. Biol. Chem.
273,
12267-12273
|
| 64.
|
Sugita, S.,
Hata, Y.,
and Südhof, T. C.
(1996)
J. Biol. Chem.
271,
1262-1265
|
| 65.
|
Schiavo, G.,
Gmachl, M. J.,
Stenbeck, G.,
Söllner, T. H.,
and Rothman, J. E.
(1995)
Nature
378,
733-736
|
| 66.
|
Kim, D. K.,
and Catterall, W. A.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14782-14786
|
| 67.
|
Ubach, J.,
Lao, Y.,
Fernandez, I.,
Arac, D.,
Südhof, T. C.,
and Rizo, J.
(2001)
Biochemistry
40,
5854-5860
|
| 68.
|
Li, C.,
Ullrich, B.,
Zhang, J. Z.,
Anderson, R. G. W.,
Brose, N.,
and Südhof, T. C.
(1995)
Nature
375,
594-599
|
| 69.
|
Chapman, E. R.,
Hanson, P. I.,
An, S.,
and Jahn, R.
(1995)
J. Biol. Chem.
270,
23667-23671
|
| 70.
|
Schivell, A. E.,
Batchelor, R. H.,
and Bajjalieh, S. M.
(1996)
J. Biol. Chem.
271,
27770-27775
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Lingwood, S. Schuck, C. Ferguson, M. J. Gerl, and K. Simons
Generation of Cubic Membranes by Controlled Homotypic Interaction of Membrane Proteins in the Endoplasmic Reticulum
J. Biol. Chem.,
May 1, 2009;
284(18):
12041 - 12048.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Hinson and P. Cresswell
The N-terminal Amphipathic {alpha}-Helix of Viperin Mediates Localization to the Cytosolic Face of the Endoplasmic Reticulum and Inhibits Protein Secretion
J. Biol. Chem.,
February 13, 2009;
284(7):
4705 - 4712.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Bhattacharya and P. Roy
Bluetongue Virus Outer Capsid Protein VP5 Interacts with Membrane Lipid Rafts via a SNARE Domain
J. Virol.,
November 1, 2008;
82(21):
10600 - 10612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Amarilio, S. Ramachandran, H. Sabanay, and S. Lev
Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein Interaction
J. Biol. Chem.,
February 18, 2005;
280(7):
5934 - 5944.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Llinas, M. Sugimori, K. A. Moran, J. E. Moreira, and M. Fukuda
Vesicular reuptake inhibition by a synaptotagmin I C2B domain antibody at the squid giant synapse
PNAS,
December 21, 2004;
101(51):
17855 - 17860.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda, E. Kanno, M. Satoh, C. Saegusa, and A. Yamamoto
Synaptotagmin VII Is Targeted to Dense-core Vesicles and Regulates Their Ca2+-dependent Exocytosis in PC12 Cells
J. Biol. Chem.,
December 10, 2004;
279(50):
52677 - 52684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda and A. Yamamoto
Effect of Forskolin on Synaptotagmin IV Protein Trafficking in PC12 Cells
J. Biochem.,
August 1, 2004;
136(2):
245 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda and T. Itoh
Slac2-a/Melanophilin Contains Multiple PEST-like Sequences That Are Highly Sensitive to Proteolysis
J. Biol. Chem.,
May 21, 2004;
279(21):
22314 - 22321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Snapp, R. S. Hegde, M. Francolini, F. Lombardo, S. Colombo, E. Pedrazzini, N. Borgese, and J. Lippincott-Schwartz
Formation of stacked ER cisternae by low affinity protein interactions
J. Cell Biol.,
October 27, 2003;
163(2):
257 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda
Molecular Cloning, Expression, and Characterization of a Novel Class of Synaptotagmin (Syt XIV) Conserved from Drosophila to Humans
J. Biochem.,
May 1, 2003;
133(5):
641 - 649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda, E. Kanno, Y. Ogata, C. Saegusa, T. Kim, Y. P. Loh, and A. Yamamoto
Nerve Growth Factor-dependent Sorting of Synaptotagmin IV Protein to Mature Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem.,
January 24, 2003;
278(5):
3220 - 3226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda
Synaptotagmin-like Protein (Slp) Homology Domain 1 of Slac2-a/Melanophilin Is a Critical Determinant of GTP-dependent Specific Binding to Rab27A
J. Biol. Chem.,
October 11, 2002;
277(42):
40118 - 40124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fukuda
Vesicle-associated Membrane Protein-2/Synaptobrevin Binding to Synaptotagmin I Promotes O-Glycosylation of Synaptotagmin I
J. Biol. Chem.,
August 9, 2002;
277(33):
30351 - 30358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Saegusa, M. Fukuda, and K. Mikoshiba
Synaptotagmin V Is Targeted to Dense-core Vesicles That Undergo Calcium-dependent Exocytosis in PC12 Cells
J. Biol. Chem.,
June 28, 2002;
277(27):
24499 - 24505.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|